- Home
- MTSI vs PODD Comparison
MTSI vs PODD Comparison
Compare MTSI & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTSI | PODD |
|---|---|---|
| Founded | 1950 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.3B | 17.0B |
| IPO Year | 2011 | 2007 |
Fundamental Metrics
Financial Performance| Metric | MTSI | PODD |
|---|---|---|
| Price | $228.93 | $218.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 20 |
| Target Price | $242.89 | ★ $357.65 |
| AVG Volume (30 Days) | ★ 1.0M | 851.5K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.64 | ★ 3.48 |
| Revenue | $967,258,000.00 | ★ $2,708,100,000.00 |
| Revenue This Year | $23.55 | $24.33 |
| Revenue Next Year | $17.74 | $19.33 |
| P/E Ratio | $382.81 | ★ $62.05 |
| Revenue Growth | ★ 32.58 | 30.73 |
| 52 Week Low | $84.10 | $215.26 |
| 52 Week High | $258.98 | $354.88 |
Technical Indicators
Market Signals| Indicator | MTSI | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 50.19 | 32.49 |
| Support Level | $203.12 | $216.49 |
| Resistance Level | $230.82 | $299.75 |
| Average True Range (ATR) | 10.91 | 7.54 |
| MACD | 1.09 | -0.61 |
| Stochastic Oscillator | 60.91 | 10.98 |
Price Performance
Historical ComparisonAbout MTSI MACOM Technology Solutions Holdings Inc.
MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.